Iterum Therapeutics ( (ITRM) ) has released its Q3 earnings. Here is a breakdown of the information Iterum Therapeutics presented to its ...

Research and development (R&D) expenses for the third quarter 2024 were $3.1 million compared to $14.9 million for the same period in 2023. The decrease for the three-month period was primarily due to ...

Company to Host Conference Call Today at 8:30 a.m. EDT-- DUBLIN and CHICAGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), (Iterum), a company focused on delivering next ...

DUBLIN and CHICAGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat infections ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Hello, everyone, and thank you for holding, and welcome to the ...

Replacing intravenous antibiotics with effective oral antibiotics in the treatment of serious infections (community-acquired pneumonia, nosocomial pneumonia, and urinary tract infections ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025 Reiterate cash runway into ...

Despite the fact that sepsis causes an estimated 350,000 deaths in the U.S. each year, fewer than half of all Americans have ever even heard the term “sepsis,” according to ...

Treatment is more involved if a UTI reaches the kidneys. You'll likely need to spend a few days in the hospital and receive antibiotics and intravenous (IV) fluids. You may need IV antibiotic ...

Opens in a new tab or window SAN DIEGO -- Antibiotic prophylaxis ... had grade I to IV vesicoureteral reflux diagnosed after a first or second febrile or symptomatic UTI. The eGFR change was ...

Rising antibiotic resistance ... that confer resistance to third generation cephalosporins. Complicated urinary tract infections (cUTI) or as step-down treatment after intravenous antibacterial ...

This medication is beta-lactam antibiotic ... such as UTI, meningitis, gonorrhea, pneumonia, bronchitis, ear, lung, skin and respiratory tract infections. Adult- PO/IM/IV- The recommended dose ...